RegeneRx Biopharmaceuticals, Inc.
RegeneRx Biopharmaceuticals, Inc. financial statements
RegeneRx Biopharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2022
| Revenue | USD 76.76K | EODHD |
| Net income | −USD 1.73M | EODHD |
| Cash and equivalents | USD 290.89K | EODHD |
RegeneRx Biopharmaceuticals, Inc. financials on 6ix · RegeneRx Biopharmaceuticals, Inc. on 6ix